Korea Investment Corp
HZNP

Korea Investment Corp’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Korea Investment Corp’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-96,813
Closed -$11.2M – 764
2023
Q3 		$11.2M Sell
96,813
-123,377
-56% -$13.3M 0.03% 390
2023
Q2 		$22.6M Buy
220,190
+167,885
+321% +$17.7M 0.06% 294
2023
Q1 		$5.71M Sell
52,305
-107,656
-67% -$11.9M 0.02% 504
2022
Q4 		$18.2M Buy
159,961
+41,448
+35% +$3.44M 0.06% 311
2022
Q3 		$7.33M Buy
118,513
+57,678
+95% +$4.03M 0.02% 474
2022
Q2 		$4.85M Sell
60,835
-111,227
-65% -$10.5M 0.01% 563
2022
Q1 		$18.1M Buy
172,062
+85,227
+98% +$8.31M 0.04% 337
2021
Q4 		$9.36M Buy
86,835
+73,535
+553% +$8.02M 0.02% 404
2021
Q3 		$1.46M Sell
13,300
-33,200
-71% -$3.45M ﹤0.01% 686
2021
Q2 		$4.35M Sell
46,500
-3,600
-7% -$331K 0.01% 558
2021
Q1 		$4.61M Sell
50,100
-21,000
-30% -$1.77M 0.01% 512
2020
Q4 		$5.2M Buy
+71,100
New +$5.28M 0.02% 477

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Korea Investment Corp's HZNP Position: Q4 2023 in Review

Korea Investment Corp sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 96,813 shares — an estimated $11.2M sold.

Korea Investment Corp first reported a position in HZNP in Q4 2020 and held it in 12 quarters. The position peaked at $22.6M in Q2 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Korea Investment Corp reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Korea Investment Corp sold 96,813 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $11.2M.
  • Korea Investment Corp first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 12 quarters.
  • Korea Investment Corp's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $22.6M in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Korea Investment Corp's 13F filing for Q4 2023, filed 13 Feb 2024.